Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma.
Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, Ellen S, Phipps-Nelson J, Lai-Kwon J, Milne D, Russell L, Dax V, Diggens J, Kent H, Button-Sloan A, Elliott J, Shackleton M, Burridge H, Ftanou M. Lynch FA, et al. Among authors: shackleton m. J Clin Med. 2020 Sep 14;9(9):2969. doi: 10.3390/jcm9092969. J Clin Med. 2020. PMID: 32937942 Free PMC article.
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper.
Jobson D, Roffey B, Best R, Button-Sloan A, Cossio D, Evans S, Shang C, Moore J, Arnold C, Mann G, Shackleton M, Soyer HP, Morton RL, Zalcberg J, Mar V. Jobson D, et al. Among authors: shackleton m. BMJ Open. 2022 Sep 2;12(9):e062139. doi: 10.1136/bmjopen-2022-062139. BMJ Open. 2022. PMID: 36691164 Free PMC article.
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma.
Edwards JM, Andrews MC, Burridge H, Smith R, Owens C, Edinger M, Pilkington K, Desfrancois J, Shackleton M, Senthi S, van Zelm MC. Edwards JM, et al. Among authors: shackleton m. Clin Transl Immunology. 2023 Sep 7;12(9):e1466. doi: 10.1002/cti2.1466. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37692904 Free PMC article.
An update on adjuvant systemic therapies in melanoma.
Samuel E, Moore M, Voskoboynik M, Shackleton M, Haydon A. Samuel E, et al. Among authors: shackleton m. Melanoma Manag. 2019 Nov 13;6(3):MMT28. doi: 10.2217/mmt-2019-0009. Melanoma Manag. 2019. PMID: 31807279 Free PMC article. Review.
Moving targets that drive cancer progression.
Shackleton M. Shackleton M. N Engl J Med. 2010 Aug 26;363(9):885-6. doi: 10.1056/NEJMcibr1006328. N Engl J Med. 2010. PMID: 20818851 No abstract available.
Current management of advanced melanoma: a transformed landscape.
Gyorki DE, Spillane J, Speakman D, Shackleton M, Henderson MA. Gyorki DE, et al. Among authors: shackleton m. ANZ J Surg. 2014 Sep;84(9):612-7. doi: 10.1111/ans.12673. Epub 2014 May 20. ANZ J Surg. 2014. PMID: 24842394 Review.
Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma.
Zhang X, Tang JZ, Vergara IA, Zhang Y, Szeto P, Yang L, Mintoff C, Colebatch A, McIntosh L, Mitchell KA, Shaw E, Rizos H, Long GV, Hayward N, McArthur GA, Papenfuss AT, Harvey KF, Shackleton M. Zhang X, et al. Among authors: shackleton m. Mol Cancer Res. 2019 Jul;17(7):1435-1449. doi: 10.1158/1541-7786.MCR-18-0407. Epub 2019 Mar 4. Mol Cancer Res. 2019. PMID: 30833299
Improving regional access: Phase 1 teletrials in the era of COVID-19.
Gaughran G, Zalcberg J, Hawkins CA, Shackleton M, Voskoboynik M. Gaughran G, et al. Among authors: shackleton m. Asia Pac J Clin Oncol. 2021 Aug;17(4):416-417. doi: 10.1111/ajco.13558. Asia Pac J Clin Oncol. 2021. PMID: 34291568 Free PMC article. No abstract available.
176 results